Danaher Corp. (0R2B)
LSE
Closed
Oct 7, 2026
Day's Range
212.0052 wk Range
159.95Overview - 0R2B - Danaher Corp.
Key Statistics
Valuation
Enterprise Value
180.83B
P/E (Trailing)
‪0.25‬
Price / Book
‪2.99‬
EV / EBITDA
‪22.52‬
Profitability
Profit Margin
‪15.94%‬
Operating Margin
‪19.77%‬
Return on Assets
‪3.94%‬
Return on Equity
‪7.60%‬
Ownership
Shares Outstanding
700.90M
Float
625.86M
Held by Insiders
‪10.96%‬
Held by Institutions
‪84.40%‬
Price stats
Beta
‪0.80‬
50-Day Avg
‪242.48‬
200-Day Avg
‪235.35‬
Dividends
Frequency
Quarterly
Market Cap - 0R2B - Danaher Corp.
Peers - 0R2B - Danaher Corp.
Peer Comparison
Compared with companies in Diagnostics & Research listed on LSE.
- 0R2BLSEDanaher Corp.156.84BMarket Cap+16.73%52-week change0.26P/E (Trailing)‪15.94%‬Profit Margin
- 0R0HLSEThermo Fisher Scientific Inc.270.26BMarket Cap+31.11%52-week change0.35P/E (Trailing)‪15.03%‬Profit Margin
- MTOLSEMitie Group plc262.06BMarket Cap+34.38%52-week change34.77P/E (Trailing)‪1.47%‬Profit Margin
- SHCLSEShaftesbury Capital PLC251.54BMarket Cap-2.55%52-week change6.63P/E (Trailing)‪156.72%‬Profit Margin
- 0JDMLSEIQVIA Holdings Inc.54.85BMarket Cap+34.03%52-week change0.49P/E (Trailing)‪8.09%‬Profit Margin
- 0HAVLSEAgilent Technologies Inc.54.73BMarket Cap+28.24%52-week change0.41P/E (Trailing)‪19.53%‬Profit Margin
- 0J8PLSEIDEXX Laboratories, Inc.44.71BMarket Cap-21.61%52-week change0.61P/E (Trailing)‪25.03%‬Profit Margin
Profile Summary - 0R2B - Danaher Corp.
About
Danaher Corp. is a global science and technology company focused on biotechnology, life sciences, and diagnostics. The company develops and supplies mission-critical tools, consumables, instruments, software, and services used in research, bioprocessing, clinical testing, and laboratory workflows. Its current business…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
